Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desflurane vs Propofol on CTC in Pancreatic Cancer Surgery
NCT02335151Phase 4Completed
- Sponsor
- University of Zurich
- Start
- Oct 2016
- Primary completion
- Sep 2019
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of desflurane in pancreatic adenocarcinoma (PDAC), sponsored by University of Zurich. Started Oct 2016; status: completed.
02
Drugs
desflurane
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02335151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02335151.